ESCRS - Supplement: Keys to Maximizing Outcomes for Today’s PresbyopiaCorrection Cataract Patients
Supplements

Supplement: Keys to Maximizing Outcomes for Today’s PresbyopiaCorrection Cataract Patients

Supplement: Keys to Maximizing Outcomes for Today’s PresbyopiaCorrection Cataract Patients

The European Society of Cataract and Refractive Surgeons (ESCRS) conducts an annual Clinical Trends Survey to understand the practice pat-terns and clinical opinion of its delegates. In 2021, during the 39th ESCRS Congress, the seventh annual survey posed 154 questions pertaining to cataract and refractive surgery, the ocular surface, and glaucoma, and received responses from 1574 delegates. The insights gained from these responses provide a snapshot of clinical practice in the real world and, when consolidated over the past 6 years, an opportunity to see how the field is evolving.

Supplement: Keys to Maximizing Outcomes for Today’s PresbyopiaCorrection Cataract Patients

Tags: cataract and refractive
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...